Specifically, a significant increase in circulating CD4+ and CD8+ T lymphocytes was found upon recognition of leukemia-associated antigens (LAA) suggesting ecto-CALR and ICD stimulation as a potential strategy to improve clinical patients’ outcomes in AML [60,61]. The gene discussed is CALR; the disease is acute myeloid leukemia.